Athanor Capital, LP Nevro Corp Transaction History

Athanor Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$132.81 - $182.18 $205,324 - $281,650	-1,546 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $213,610 - $284,989	1,546 New	1,546 $268,000
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $288,305 - $367,703	-2,527 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$89.45 - $129.85 $226,040 - $328,130	2,527 New	2,527 $302,000
Q1 2020 May 14, 2020	SELL	$70.23 - $144.31 $217,713 - $447,361	-3,100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $236,871 - $364,374	3,100 New	3,100 $364,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $163M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.